Silodosin Capsule
Product Images NDC 69238-1420

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Silodosin (NDC 69238-1420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Silodosin Capsules 1)

Chemical structure of silodosin, a compound depicted by its molecular framework including aromatic rings, ether, amide, and hydroxyl functional groups.*

FDA Label Image

Fig1 (Silodosin Capsules 2)

A line graph showing silodosin concentration (ng/mL) over time (hours) up to 24 hours, with error bars indicating variability at each time point, illustrating the pharmacokinetic profile of silodosin after administration.*

FDA Label Image

Fig2 (Silodosin Capsules 3)

A line graph comparing the change from baseline in IPSS total score between placebo and Silodosin 8 mg over a period including baseline and multiple days up to 84 or last observation carried forward (LOCF). The graph shows greater improvement (decrease in score) for Silodosin 8 mg compared to placebo, with statistical significance indicated.*

FDA Label Image

Fig3 (Silodosin Capsules 4)

A line graph comparing change from baseline in IPSS Total Score over days between placebo and Silodosin 8 mg groups. The x-axis represents days, and the y-axis shows score changes, highlighting greater improvement with Silodosin 8 mg versus placebo.*

FDA Label Image

Fig4 (Silodosin Capsules 5)

A line graph comparing the change from baseline in Cmax (mL/sec) over days between Placebo and Silodosin 8 mg groups. The x-axis represents days with labeled points B, 1, 7, 14, 28, and 84/LOCF, and the y-axis shows the change from baseline in Cmax. The Silodosin 8 mg group shows a consistently higher change than the placebo, with statistical significance indicated (p<0.05).*

FDA Label Image

Fig5 (Silodosin Capsules 6)

A line graph comparing the change from baseline in Cmax (maximum concentration, mL/sec) over days between placebo and Silodosin 8 mg groups. The X-axis represents days while the Y-axis shows change in Cmax. Silodosin shows a consistently higher Cmax change than placebo, with indications of statistical significance at later time points.*

FDA Label Image

4 mg (Silodosin Capsules 7)

Silodosin Capsules 4 mg label showing a bottle containing 30 capsules. The label includes dosage form as oral capsules, and the product is manufactured by Amneal Pharmaceuticals Pvt. Ltd. with distribution by Amneal Pharmaceuticals LLC. The label also lists storage instructions, a barcode, and states the product is prescription only.*

FDA Label Image

8 mg (Silodosin Capsules 8)

Silodosin Capsules 8 mg oral capsules package label from Amneal Pharmaceuticals NY LLC. The label includes dosage information stating one capsule orally once daily with a meal, storage conditions (20° to 25°C, excursions permitted 15° to 30°C), and a caution to keep out of reach of children. The package contains 30 capsules. Manufacturer is Amneal Pharmaceuticals Pvt. Ltd., India, with distribution by Amneal Pharmaceuticals LLC, New Jersey.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.